van den Berg RH - Search Results

1

Inhibition of activation of the classical pathway of complement by human neutrophil defensins.

van den Berg RH, Faber-Krol MC, van Wetering S, Hiemstra PS, Daha MR. van den Berg RH, et al. Blood. 1998 Nov 15;92(10):3898-903. Blood. 1998. PMID: 9808583 Free article.

2

Regulation of the function of the first component of complement by human C1q receptor.

van den Berg RH, Faber-Krol M, van Es LA, Daha MR. van den Berg RH, et al. Eur J Immunol. 1995 Aug;25(8):2206-10. doi: 10.1002/eji.1830250814. Eur J Immunol. 1995. PMID: 7664783

3

Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.

van den Berg RH, Faber-Krol MC, van de Klundert JA, van Es LA, Daha MR. van den Berg RH, et al. J Immunol. 1996 Jun 1;156(11):4466-73. J Immunol. 1996. PMID: 8666822

4

Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).

van den Berg RH, Siegert CE, Faber-Krol MC, Huizinga TW, van Es LA, Daha MR. van den Berg RH, et al. Clin Exp Immunol. 1998 Feb;111(2):359-64. doi: 10.1046/j.1365-2249.1998.00473.x. Clin Exp Immunol. 1998. PMID: 9486404 Free PMC article.

5

The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells.

van den Berg RH, Faber-Krol MC, Sim RB, Daha MR. van den Berg RH, et al. J Immunol. 1998 Dec 15;161(12):6924-30. J Immunol. 1998. PMID: 9862726

6

Intracellular localization of the human receptor for the globular domains of C1q.

van den Berg RH, Prins F, Faber-Krol MC, Lynch NJ, Schwaeble W, van Es LA, Daha MR. van den Berg RH, et al. J Immunol. 1997 Apr 15;158(8):3909-16. J Immunol. 1997. PMID: 9103461

7

Characterisation of the rat and mouse homologues of gC1qBP, a 33 kDa glycoprotein that binds to the globular 'heads' of C1q.

Lynch NJ, Reid KB, van den Berg RH, Daha MR, Leigh LA, Ghebrehiwet B, Lim WB, Schwaeble WJ. Lynch NJ, et al. Among authors: van den berg rh. FEBS Lett. 1997 Nov 24;418(1-2):111-4. doi: 10.1016/s0014-5793(97)01348-3. FEBS Lett. 1997. PMID: 9414106 Free article.

8

HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS).

Rischmueller M, Lester S, Chen Z, Champion G, Van Den Berg R, Beer R, Coates T, McCluskey J, Gordon T. Rischmueller M, et al. Clin Exp Immunol. 1998 Feb;111(2):365-71. doi: 10.1046/j.1365-2249.1998.00504.x. Clin Exp Immunol. 1998. PMID: 9486405 Free PMC article.

9

Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5.

Peijnenburg A, Van Eggermond MJ, Gobin SJ, Van den Berg R, Godthelp BC, Vossen JM, Van den Elsen PJ. Peijnenburg A, et al. J Immunol. 1999 Jul 15;163(2):794-801. J Immunol. 1999. PMID: 10395672

10

Regulation of alpha1,3galactosyltransferase expression in pig endothelial cells. Implications for xenotransplantation.

Mercier D, Charreau B, Wierinckx A, Keijser R, Adriaensens L, van den Berg R, Joziasse DH. Mercier D, et al. Eur J Biochem. 2002 Mar;269(5):1464-73. doi: 10.1046/j.1432-1033.2002.02791.x. Eur J Biochem. 2002. PMID: 11874461 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters